ViroGates A/S (OCSE:VIRO) Long-Term Debt : kr5.30 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Long-Term Debt?

ViroGates A/S's Long-Term Debt for the quarter that ended in Mar. 2024 was kr5.30 Mil.

ViroGates A/S's quarterly Long-Term Debt stayed the same from Sep. 2023 (kr5.30 Mil) to Dec. 2023 (kr5.30 Mil) and stayed the same from Dec. 2023 (kr5.30 Mil) to Mar. 2024 (kr5.30 Mil).

ViroGates A/S's annual Long-Term Debt stayed the same from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.00 Mil) but then increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr5.30 Mil).

ViroGates A/S Long-Term Debt Historical Data

The historical data trend for ViroGates A/S's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Long-Term Debt Chart

ViroGates A/S Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

5.30

ViroGates A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															-	5.30	5.30	5.30	5.30

ViroGates A/S (OCSE:VIRO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

ViroGates A/S Long-Term Debt Related Terms

Thank you for viewing the detailed overview of ViroGates A/S's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ViroGates A/S (OCSE:VIRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Banevaenget 13, Birkerod, DNK, DK-3460

Website

https://www.virogates.com

ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines